A Cancer Prevention Researcher is a scientific professional dedicated to studying the causes of cancer and identifying strategies to reduce its incidence. Their work focuses on understanding how genetics, lifestyle, environmental exposures, and early biological changes contribute to cancer development. By investigating risk factors such as diet, tobacco use, physical inactivity, infections, and occupational hazards, these researchers aim to design effective interventions that can stop cancer before it starts. They also explore the role of vaccines, screening tools, and chemopreventive agents in reducing cancer risk across various populations. Their efforts are essential in shaping evidence-based guidelines and public health policies that support long-term cancer prevention.
Cancer Prevention Researchers collaborate with epidemiologists, clinicians, behavioral scientists, and policymakers to implement and evaluate prevention programs. They often conduct large-scale studies, analyze population health data, and engage in community outreach to promote awareness and early action. Their work informs cancer education campaigns, early detection strategies, and risk-reduction initiatives tailored to diverse demographics. As cancer prevention continues to gain global importance, these researchers play a critical role in reducing the future burden of cancer through proactive, science-driven solutions. Their contributions not only improve individual health outcomes but also create healthier communities through sustainable, preventative approaches.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China